Clofibrate

In the US, Clofibrate (clofibrate systemic) is a member of the drug class fibric acid derivatives and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type III - Elevated beta-VLDL IDL, Hyperlipoproteinemia Type IV - Elevated VLDL and Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL.

US matches:

• Clofibrate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AB01

CAS registry number (Chemical Abstracts Service)

0000637-07-0

Chemical Formula

C12-H15-Cl-O3

Molecular Weight

242

Therapeutic Category

Antilipemic agent, fibrate

Chemical Name

Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, ethyl ester

Foreign Names

• Clofibratum (Latin)
• Clofibrat (German)
• Clofibrate (French)
• Clofibrato (Spanish)

Generic Names

• Clofibrate (OS: USAN, DCF, JAN, BAN)
• Clofibrato (OS: DCIT)
• AY 61123 (IS)
• Chlorfenisate (IS)
• Chlorophenisate (IS)
• ICI 28257 (IS)
• Lipomid (IS)
• NSC 79389 (IS)
• Sklerolip (IS)
• Clofibrat (PH: Ph. Eur. 6)
• Clofibrate (PH: BP 2010, JP XV, USP 32, Ph. Eur. 6)
• Clofibratum (PH: Ph. Eur. 6)

Brand Names

• Binograc
  Kotobuki Seiyaku, Japan



• Clobrate
  Johnson, Taiwan



• Clofibrate
  Banner Pharmacaps, United States; Gallipot, United States; USL Pharma, United States



• Elpi
  Elea, Argentina



• Hypocerol
  Fuso Pharmaceutical, Japan



• Lipilim
  Atlantic, Hong Kong

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.